How much passive income do you need from your ISA to retire at 60?

Passive income is the holy grail of investing for many of us. And who wouldnât want to earn while they sleep? Nonetheless, generating steady income without excessive risk takes more than luck. It takes discipline, patience, and a keen eye for value.
Reaching retirement at 60 with enough passive income to live comfortably depends on two key factors. These are: how much is needed to cover annual expenses, and how reliably can that income be generated?
For most investors, the goal isnât simply to stop working, but to reach a point where investment income replaces the paycheque without eroding the capital base â the money in the portfolio.
A Stocks and Shares ISA is an ideal vehicle for this. Its tax-free status means every pound of dividend or interest income can be kept in full. This helps returns compound faster over time.
That advantage becomes particularly powerful over decades, especially if the investor regularly contributes the annual allowance.
So, how much passive income does one need to retire at 60?
Well, someone planning a modest retirement might target £20,000â£25,000 a year, while a more comfortable lifestyle could require £35,000 or more.
Translating those figures into investment terms depends on expected yield. A portfolio yielding 4% would need roughly £625,000 to generate £25,000 annually.
This could be complemented by a personal or state pension.
Running the maths
Ok, so how does one build a portfolio worth £625,000 in an ISA?
Well, letâs look at the maths.
Starting with nothing, and assuming 8% annualised growth, an investor would need to contribute £500 per month for 28 years.
But what if you donât have 28 years?
It would take 20.5 years when investing £1,000 per month â assuming 8% annualised growth.
And if the rate of growth were stronger?
£1,000 and an annualised return of 12% would mean hitting target in just 16 years.
Knowing where to invest
For novice investors, knowing where to invest can feel incredibly daunting. This is why many will opt for index-tracking funds as a starting point.
However, investors willing to take a more active approach may consider investing in individual stocks to beat the market.
AstraZeneca (LSE:AZN) â the largest company on the UK index â is definitely worth considering, especially after easing US tariff pressures through a $4.5bn commitment to expand manufacturing in Virginia.
The move strengthens its relationship with Washington and supports its plan to generate half its projected $80bn in 2030 revenue from the US market.
Trading around 18 times forward earnings, the stock sits at a modest discount to the pharma sector, while forecast annual earnings growth of nearly 15% gives a price-to-earnings-to-growth (PEG) ratio of 1.2 â about 33% below the industry average.
The main risk is inherent to the sector. Heavy R&D spending doesnât always lead to marketable breakthroughs.
However, AstraZenecaâs strong oncology focus and vast drug pipeline offer scope for sustained long-term growth and mitigates some of the R&D risk.
If an investor already has £625,000 and theyâre looking for a passive income, however, there may be better dividend-paying stocks out there.
The post How much passive income do you need from your ISA to retire at 60? appeared first on The Motley Fool UK.
Should you invest £1,000 in AstraZeneca PLC right now?
When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.
And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca PLC made the list?
More reading
- Here’s when the next stock market crash will happen, according to this billionaire investor!
- Worried about buying at the top of the market? Look closer at this FTSE 100 giant
- Up 22% in 3 months! Should investors consider buying shares in this FTSE 100 pharma giant?
- £20,000 invested in AstraZeneca shares 6 months ago is now worthâ¦
- Could an S&P 500 crash hit the FTSE 100? Hereâs what the experts think…
James Fox has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
